Lot I-10-7, D7 Street, Saigon Hi-Tech Park, Tang Nhon Phu Ward, Thu Duc City, HCMC
Lot I-10-7, D7 Street, Saigon Hi-Tech Park, Tang Nhon Phu Ward, Thu Duc City, HCMC
(+84) 28 7301 3688
(+84) 28 7301 3688
Info@wembleymed.com.vn
Info@wembleymed.com.vn

Platelet-Rich Plasma (PRP): An Effective - Minimally Invasive Solution for Osteoarthritis Treatment

Author

Master of Medicine, Dr. Tran Van Hien – Medical Director at WEMBLEY MEDICAL
Medical Doctor (MD), Master of Medicine (MMed) – Cornell University, USA

https://www.wembleymed.com.vn/vi/medical-news/doi-ngu-chuyen-gia/thsbs-tran-van-hien/
Author

Osteoarthritis (OA) is a common joint disease that causes pain and significantly affects mobility, especially among middle-aged and elderly people. Among modern treatment methods, platelet-rich plasma (PRP) therapy is emerging as a promising solution. By using platelets from the patient’s own blood, PRP helps regenerate cartilage, reduce inflammation, and improve joint function. In this article, WEMBLEY MEDICAL will help you better understand the effectiveness, process, and important considerations of PRP treatment for osteoarthritis.

1. Overview of Osteoarthritis

Osteoarthritis is a widespread condition in which the protective cartilage cushioning the ends of bones wears down over time. While it can affect any joint, it most often impacts hands, hips, knees, and spine. Common symptoms include:

  • Joint pain during or after movement

  • Joint stiffness, especially after periods of inactivity

  • Decreased joint flexibility and limited range of motion

  • Clicking or grinding noises in the joint during movement

  • Bone spurs forming around the affected joint

  • Swelling due to inflammation of surrounding soft tissues

Osteoarthritis is a common form of arthritis that typically occurs in middle-aged and elderly individuals.

2. Treating Osteoarthritis with Platelet-Rich Plasma (PRP)

PRP therapy involves injecting the patient’s own concentrated platelets into the affected joint to accelerate healing. Blood contains solid components (red blood cells, white blood cells, and platelets), each with specific functions. Platelets play a crucial role in clotting and contain hundreds of proteins essential for tissue repair.

PRP refers to plasma with platelet concentrations 5–10 times higher than normal. To prepare it, platelets are separated from other blood cells and concentrated by centrifugation. When injected into the damaged joint, platelets release growth factors that:

  • Suppress inflammation and slow the progression of osteoarthritis

  • Stimulate the formation of new cartilage

  • Increase production of natural joint lubricants to reduce friction and pain

  • Release proteins that alter pain receptors, reducing pain perception
Platelet-rich plasma is a plasma solution with a platelet concentration several times higher than norma

3. Mechanism of Platelet-Rich Plasma (PRP)

The exact mechanism of PRP is not fully understood. However, laboratory studies have shown that growth factors in PRP (such as IGF, KGF, VEGF) are soluble macromolecules produced by various cells. They influence the growth, differentiation, and behavior of many cell types, including chondrocytes (cartilage cells).

These molecules bind to cell membrane receptors, transmitting signals that regulate gene expression through paracrine, autocrine, or sometimes endocrine mechanisms. This cascade triggers cartilage regeneration effectively regardless of patient age or disease stage, without damaging cartilage or the synovial membrane.

Platelet-rich plasma (PRP) injection for the treatment of knee osteoarthritis.

4. Comparison with Conventional Treatments

Compared to traditional therapies, PRP offers several advantages:

  • Pain reduction: PRP injections significantly relieve pain compared to placebo.

  • Physical function: PRP improves joint mobility and physical function better than conventional control measures.

  • Side effects: Although PRP carries some risks, they are generally no greater than those of traditional intra-articular treatments.

5. PRP Treatment Procedure for Osteoarthritis

The procedure for treating osteoarthritis with platelet-rich plasma (PRP) injections is performed as follows:
Step 1: The doctor draws blood from the patient’s arm vein into a collection tube, usually about 15–50 ml.

Step 2: The blood is processed using a centrifuge.

Step 3: The doctor prepares the platelet-rich plasma for injection.

Step 4: The doctor cleans the affected joint area with a disinfectant, such as alcohol or iodine.

Step 5: If ultrasound method is used, a special gel is applied to the skin near the injection site. Then, a probe is pressed against the gel-covered skin to provide real-time images of the joint on a monitor for doctor observe.

Step 6: The Medical Staff asks the patient to relax to facilitate the injection and minimize pain feelings.

Step 7: Once the syringe and needle are ready, the doctor injects a small amount of platelet-rich plasma (typically 3–6 ml) into the joint capsule.

Step 8: After the injection, the area is cleaned and bandaged.

Step 9: Since platelet-rich plasma stimulates a series of biological responses, mild swelling and pain at the injection site may occur for about 3 days.

PRP therapy procedure following the VATRACY PRP Platelet-Rich Plasma Isolation Kit standard by WEMBLEY MEDICAL

To ensure the PRP separation and injection process is effective, safe, and consistent, the use of specialized kits is increasingly important in clinical practice.

The VATRACY PRP Platelet-Rich Plasma Isolation Kit by WEMBLEY MEDICAL is a comprehensive solution designed to optimize procedures, standardize operations, and enhance treatment outcomes. Its closed, sterile design enables the extraction of PRP with high platelet concentration and superior purity, while minimizing infection risks. This is an ideal choice for hospitals, clinics specializing in musculoskeletal and rehabilitation medicine.

VATRACY - ULTIMATE PRP Platelet-Rich Plasma Isolation Kit, designed and manufactured by WEMBLEY MEDICAL

6. Suitable Candidates

While there’s no definitive guideline on who should receive PRP, it is commonly recommended for:

  • Young patients with early-stage osteoarthritis

  • Patients unresponsive to rest, physiotherapy, or NSAIDs

  • Those with severe joint pain impacting daily activities

  • Patients intolerant to NSAIDs or unresponsive to corticosteroid injections

  • PRP therapy may be suitable for people with severe osteoarthritis and severe pain.

PRP therapy may be suitable for patients with severe osteoarthritis and significant pain symptoms.

7. Possible Complications

Although PRP uses the patient’s own blood, injection can still carry risks such as:

  • Local infection

  • Pain at the injection site
    Nerve injury

  • Joint stiffness

  • Rapid heartbeat

  • Dizziness or fainting

  • Nausea or abdominal discomfort

  • Excessive sweating
    Headache

These complications are rare and typically no worse than those associated with other intra-articular treatments.

8. Important Precautions

Patients can be injected only once or multiple injections spaced weeks or months apart, depending on the type of injury. In cases requiring multiple injections, the doctor may recommend drawing blood during the first visit, using fresh PRP for the initial treatment, and freezing then thawing the PRP for subsequent sessions. Below are some important notes to keep in mind:

Before the injection:

  • Avoid corticosteroids for 2–3 weeks beforehand.
    Discontinue NSAIDs 1 week prior.

  • Stop anticoagulants 5 days before.
    Stay hydrated the day before the procedure.

  • Some patients may need an anti-anxiety medication right before the injection.

After the injection:

  • Rest for several days to avoid straining the joint.

  • Avoid taking NSAIDs unless prescribed.

  • Use a brace or support if recommended.

  • Crutches may be needed if the ankle, knee, or hip is treated.

  • Apply ice packs for 10–20 minutes several times a day to reduce swelling.

Conclusion

Platelet-rich plasma (PRP) is a modern, safe treatment using the patient’s own blood to trigger natural healing. By reducing inflammation, regenerating cartilage, and improving joint function, PRP offers new hope for those suffering from osteoarthritis. For best results, patients should strictly follow their doctor’s instructions.

.

The VATRACY PRP Platelet-Rich Plasma Isolation Kit, specially designed for osteoarthritis treatment, manufactured by WEMBLEY MEDICAL is a reliable choice for hospitals and medical facilities, supporting the PRP extraction and injection process with efficiency, precision, and sterile assurance. For detailed product information, please contact our hotline at +84 28 7301 3688 for prompt assistance.

Rated 3.5/5 based on 11 customer reviews
ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits
ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits ATRACY PRP Platelet Rich Plasma Isolation Kits
PRP

ATRACY PRP Platelet Rich Plasma Isolation Kits

0
Retail:
Contact
Wholesale:
Contact
https://www.wembleymed.com.vn/en/products/prp-kit/

References:

  • Woolf A.D, Pfleger B, (2003). Burden of major musculoskeletal conditions. Bull World Health Organ. 81, 646-656.
  • Beiner J.M, Jokl P, (2001). Muscle contusion injuries:current treatment options. J Am Acad Orthop Surg. 9, 227-237.
  • Jarvinen T.A, Aarimaa V, et al (2007). Muscle injuries: optimizing recovery. Best Pract Res Clin Rheumatol. 21, 317-331.
  • Hamid M.S, Mohamed Ali M.R, et al (2014). Platelet rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med. 42, 2410-2418
  • Reurink G, Goudswaard G.J, et al (2014). Platelet rich plasma injections in acute muscle injury. N Engl J Med. 370, 2546- 2547.
  • Sanchez M, Anitua E, et al (2009). Platelet rich plasma therapies in the treatment of orthopaedic sport injuries. Sports Med. 39(5), 345-354.
  • Anitua E, Sanchez M, et al (2007). Reciprocal actions of platelet secreted TGF-beta1 on the production of VEGF and HGF by human tendon cells. Plast Reconstr Surg. 119(3), 950-959.
  • Mishra A, Pavelko T, (2006). Treatment of chronic elbow tendinosis with buffered platelet rich plasma. Am J Sports Med. 34(11), 1774-1778. 
  • Peerbooms J.C, Sluimer J, et al (2010). Possitive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet rich plasma versus corticosteroid injection with a 1 year follow up. Am J Sports Med. 38(2), 255-262.
  • Kon E, Filardo G, et al (2009). Platelet rich plasma: new clinical application: a pilot study for treatment of jumper’s knee. Injury. 40(6), 598-603.
  • Everts P.A, Devilee R.J, et al (2008). Exogenous application of platelet – leukocyte gel during open subacromial decompression contributes to improved patient outcome: a prospective randomized double-blind study. Eur Surg Res. 40(2), 203-210.
  • Foster T.E, Puskas B.L, et al (2009). Platelet rich plasma: from basic science to clinical applications. Am J Sport Med. 37, 2259-2272.
  • Radice F, Yanez R, et al (2010). Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy. 26(1), 50-57.